Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation.

Aye TT, Bartholomeusz A, Shaw T, Bowden S, Breschkin A, McMillan J, Angus P, Locarnini S.

J Hepatol. 1997 May;26(5):1148-53.

PMID:
9186847
3.

Clinical experience with famciclovir against hepatitis B virus.

Bartholomeusz A, Groenen LC, Locarnini SA.

Intervirology. 1997;40(5-6):337-42. Review.

PMID:
9675638
4.

Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.

Tillmann HL, Trautwein C, Bock T, Böker KH, Jäckel E, Glowienka M, Oldhafer K, Bruns I, Gauthier J, Condreay LD, Raab HR, Manns MP.

Hepatology. 1999 Jul;30(1):244-56.

PMID:
10385663
5.
6.

In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance.

Xiong X, Yang H, Westland CE, Zou R, Gibbs CS.

Hepatology. 2000 Jan;31(1):219-24.

PMID:
10613749
8.

Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy.

Stuyver L, Van Geyt C, De Gendt S, Van Reybroeck G, Zoulim F, Leroux-Roels G, Rossau R.

J Clin Microbiol. 2000 Feb;38(2):702-7.

9.

Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure.

Günther S, von Breunig F, Santantonio T, Jung MC, Gaeta GB, Fischer L, Sterneck M, Will H.

J Hepatol. 1999 May;30(5):749-54.

PMID:
10365797
10.

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.

Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, Tzakis AG, Schiff ER, Brown NA.

Lancet. 1997 Jan 4;349(9044):20-2.

PMID:
8988118
11.
12.

Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.

Singh N, Gayowski T, Wannstedt CF, Wagener MM, Marino IR.

Transplantation. 1997 May 27;63(10):1415-9.

PMID:
9175803
13.

Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.

Krüger M, Tillmann HL, Trautwein C, Bode U, Oldhafer K, Maschek H, Böker KH, Broelsch CE, Pichlmayr R, Manns MP.

Liver Transpl Surg. 1996 Jul;2(4):253-62.

14.

Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.

Gutfreund KS, Williams M, George R, Bain VG, Ma MM, Yoshida EM, Villeneuve JP, Fischer KP, Tyrrel DL.

J Hepatol. 2000 Sep;33(3):469-75.

PMID:
11020004
15.

Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.

Seignères B, Pichoud C, Ahmed SS, Hantz O, Trépo C, Zoulim F.

J Infect Dis. 2000 Apr;181(4):1221-33. Epub 2000 Apr 13.

PMID:
10762559
16.

Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation.

Ben-Ari Z, Daudi N, Klein A, Sulkes J, Papo O, Mor E, Samra Z, Gadba R, Shouval D, Tur-Kaspa R.

Am J Gastroenterol. 2003 Jan;98(1):151-9.

PMID:
12526951
17.

Efficacy of famciclovir treatment in chronic hepatitis B patients with different mutations at position 552 of the DNA polymerase gene.

Wolters LM, Honkoop P, Niesters HG, de Man RA.

J Hepatol. 1998 May;28(5):909-10. No abstract available.

PMID:
9625328
18.

HBV mutations associated with lamivudine therapy.

Lapiński TW, Parfieniuk-Kowerda A, Trzos A, Jaroszewicz J, Kowalczuk O, Nikliński J, Flisiak R.

Przegl Epidemiol. 2013;67(4):611-6, 705-8. English, Polish.

19.

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine.

Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ.

Hepatology. 1996 Sep;24(3):711-3.

PMID:
8781347
20.

[HBV gene variants and polymerse gene mutations in children with chronic hepatitis B in the course of the antiviral therapy].

Góra-Gebka M, Liberek A, Charmuszko U, Sikorska-Wiśniewska G, Szlagatys-Sidorkiewicz A, Korzon M, Bielawski K.

Med Wieku Rozwoj. 2007 Oct-Dec;11(4):367-71. Polish.

PMID:
18605187

Supplemental Content

Support Center